Validation of microRNA expression profile in Oral Lichenoid Disease through cytological samples

  1. Amaia Setién Olarra 1
  2. Xabier Marichalar Mendia 1
  3. Juan-Alonso Fernández-Pacheco 2
  4. Marcos Fernández Barriales 2
  5. María Luisa Gainza Cirauqui 3
  6. José Manuel Aguirre Urizar 1
  1. 1 Oral Medicine and Pathology, Department of Stomatology II, UFI 11/25, University of the Basque Country (UPV/EHU). Leioa, Spain
  2. 2 Servicio de Cirugía Maxilofacial. Hospital Universitario Araba (Osakidetza. OSI Araba). Vitoria-Gazteiz, Spain
  3. 3 Department of Dental Surgery, Faculty of Dental Surgery, University of Malta. Msida, Malta
Erakutsi afiliazioak +
Aldizkaria:
Medicina oral, patología oral y cirugía bucal. Ed. inglesa

ISSN: 1698-6946

Argitalpen urtea: 2019

Alea: 24

Zenbakia: 5

Orrialdeak: 13

Mota: Artikulua

DOI: 10.4317/MEDORAL.23020 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Medicina oral, patología oral y cirugía bucal. Ed. inglesa

Garapen Iraunkorreko Helburuak

Laburpena

To validate oral exfoliative cytology in the analysis of the microRNA expression profile in Oral Lichenoid Disease (OLD). The expression of 13 microRNAs identified and presented by our group in a previous study was analyzed in 26 cases, 16 diagnosed as OLD and 10 controls with no oral mucosal pathology. Cytological samples from the oral mucosa obtained using an Orcellex toothbrush were analyzed using RT-qPCR and TaqMan microRNA assays. The aberrant expression was validated for 2 microRNAs (miR-146a-5p and miR-7-1-3p) of those previously recognized in the biopsy study. This is the first time that oral exfoliative cytology is validated in a study of the alterations of the expression of microRNAs in OLD. The alteration of miR-146a and miR-7 compared to controls was validated. These microRNAs are associated with both inflammatory and carcinogenic phenomena that are involved in the etiopathogenesis of this potentially malignant oral disorder.

Erreferentzia bibliografikoak

  • Cortés-Ramírez, DA,Gainza-Cirauqui, ML,Echebarria-Goikouria, MA,Aguirre-Urizar, JM. (2009). Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med Oral Patol Oral Cir Bucal. 14. 118-122
  • van der Waal, I. (2009). Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 45. 317-323
  • González-Moles, MA,Scully, C,Gil-Montoya, JA. (2008). Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 14. 229-243
  • Speight, PM,Khurram, SA,Kujan, O. (2017). Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 22124403.
  • Schwartz, JL,Panda, S,Beam, C,Bach, LE,Adami, GR. (2008). RNA from brush oral cytology to measure squamous cell carcinoma gene expression. J Oral Pathol Med. 37. 70
  • Acha-Sagredo, A,Jiménez, Y,Bagán, JV,Echebarria-Goicouria, MA,Aguirre-Urizar, JM. (2011). Cytometric analysis of oral scrapings of patients with oral lichen planus. Cytopathology. 22. 106
  • He, Q,Chen, Z,Cabay, RJ,Zhang, L,Luan, X,Chen, D. (2016). microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol. 57. 15-20
  • Filipowicz, W,Bhattacharyya, SN,Sonenberg, N. (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 9. 102-114
  • Bartel, DP. (2009). MicroRNAs: target recognition and regulatory functions. Cell. 136. 215-233
  • Kent, OA,Mendell, JT. (2006). A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 25. 6188-6196
  • Cervigne, NK,Reis, PP,Machado, J,Sadikovic, B,Bradley, G,Galloni, NN. (2009). Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet. 18. 4818-4829
  • De Sarkar, N,Roy, R,Mitra, JK,Ghose, S,Chakraborty, A,Paul, RR. (2014). A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers. PLoS One. 9. 104839
  • Budhu, A,Ji, J,Wang, XW. (2010). The clinical potential of microRNAs. J Hematol Oncol. 3. 37
  • Yang, Y,Li, YX,Yang, X,Jiang, L,Zhou, ZJ,Zhu, YQ. (2013). Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer. 19. 129
  • Roy, R,Singh, R,Chattopadhyay, E,Ray, A,Sarkar, ND,Aich, R. (2016). MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues. Gene. 593. 58-63
  • Shi, W,Yang, J,Li, S,Shan, X,Liu, X,Hua, H. (2015). Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5. Oncotarget. 24. 40172
  • Setién-Olarra, A,Bediaga, NG,Acha-Sagredo, A,Marichalar-Mendia, X,de Pancorbo, MM,Aguirre-Urizar, JM. (2016). Genomewide miRNA profiling of oral lichenoid disorders and oral squamous cell carcinoma. Oral Dis. 22. 754-760
  • Silverman, S Jr. (2000). Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg. 58. 1286-1288
  • Spivack, SD,Hurteau, GJ,Jain, R,Kumar, SV,Aldous, KM,Gierthy, JF. (2004). Gene environment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res. 64. 6805
  • Arao, TC,Guimaraes, AL,de Paula, AM,Gomes, CC,Gomez, RS. (2012). Increased miRNA-146a and miRNA-155 expressions in oral lichen planus. Arch Dermatol Res. 304. 371-375
  • Gassling, V,Hampe, J,Acil, Y,Braesen, JH,Wiltfang, J,Hasler, R. (2013). Disease-associated miRNA-mRNA networks in oral lichen planus. PLoSOne. 8. 63015
  • Taganov, KD,Boldin, MP,Chang, KJ,Baltimore, D. (2006). NFkappaB- dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 103. 12481-12486
  • Bhaumik, D,Scott, GK,Schokrpur, S,Patil, CK,Campisi, J,Benz, CC. (2008). Expression of microRNA-146 suppresses NFkappa B activity with reduction of metastatic potential in breast cancer cells. Oncogene. 27. 5643-5647
  • Sonkoly, E,Stahle, M,Pivarcsi, A. (2008). MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 18. 131-140
  • Zhang, S,Hu, F,Liang, H,Liu, Y,Yang, J,Zhou, W. (2017). Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies. PLoS One. 12. 0186609
  • Hung, PS,Chang, KW,Kao, SY,Chu, TH,Liu, CJ,Lin, SC. (2012). Association between the rs2910164 polymorphism in premir- 146a and oral carcinoma progression. Oral Oncol. 48. 404
  • Kefas, B,Godlewski, J,Comeau, L,Li, Y,Abounader, R,Hawkinson, M. (2008). MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68. 3566-3572
  • Jiang, L,Liu, X,Chen, Z,Jin, Y,Heidbreder, CE,Kolokythas, A. (2010). MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J. 15. 199-205
  • Zhao, XD,Lu, YY,Guo, H,Xie, HH,He, LJ,Shen, GF. (2015). MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis. J Cell Biol. 210. 613
  • Anderson, EC,Wong, MH. (2010). Caught in the Akt: regulation of Wnt signaling in the intestine. Gastroenterology. 139. 718-722
Datuen iturria: Dialnet